12:00 AM
 | 
Apr 17, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

SangCya Oral Solution formulation of cyclosporine A regulatory update

Germany granted marketing approval for SANG's SangCya to prevent solid organ transplant rejection. SANG...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >